NEW YORK (360Dx) – Abbott's Alere business, along with Roche, Becton Dickinson, and Danaher's Cepheid each received US Food and Drug Administration clearances for tests in January, according to the FDA's website.

Alere, acquired by Abbott in October 2017, received clearances for four tests.